We will take a look at the past year in health care finance and discuss what is on the horizon for next year. We will highlight the trends and activities from 2015 that we anticipate will continue to affect health care providers, including implementation of IRS regulations, mergers, acquisitions, other combinations, and SEC enforcement actions.
Key Takeaways
- Health care provider combinations and emerging structure trends
- The Massachusetts ban on a proposed combination due to perceived cost containment issues
- The evolution of the direct placement market Lessons learned from first rounds of SEC MCDC settlement actions
- Evolution of market conditions
- Living with regulations such as 501(r) and the new allocation and accounting rules
People
Related Insights
April 16, 2026
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.
April 16, 2026
Foley Viewpoints
USPTO's AI Search Pilot May Reshape Patent Filing Strategy
The U.S. Patent and Trademark Office's Artificial Intelligence Search Automated Pilot, or ASAP, program introduces earlier visibility into the prior art landscape by providing applicants with an automated search results notice prior to substantive examination.
April 16, 2026
Foley Viewpoints
Delaware Chancery Rejects “Race to the Courthouse” in Enforcing Texas Exclusive Forum Bylaw, Dismissing Three Derivative Lawsuits filed before Tesla’s Redomestication
On April 13, 2026, the Delaware Court of Chancery dismissed three derivative suits in In re Tesla, Inc. Derivative Litigation based on Tesla’s forum selection bylaw requiring that those lawsuits be brought in Texas. All three derivative lawsuits were filed after Tesla announced its proposal to redomesticate and adopt a Texas exclusive forum bylaw but before the redomestication and amended bylaw became effective after shareholder approval.